In a cohort of TRANSCEND FL, the chimeric antigen receptor T-cell therapy liso-cel showed a 95% overall response rate in relapsed marginal zone lymphoma, offering hope for improved patient outcomes in ...

CAR T-cell therapy targeting B-cell maturation antigen (BCMA) has become a game changer for patients with relapsed or ...

Mathieu Bennet: In B-cell cloning, single-cell isolation occurs at two crucial stages. First, during the initial screening phase, high-throughput isolation is required to analyze a broad antibody ...

Bitmap Bureau, the developers behind the upcoming Terminator 2D: No Fate, joined us to discuss how they're planning on turning 1990s movie gold into a video game success worthy of the film's classic ...

This held true for all the investigated target antigens (CD33, CD123) expressed on MOLM13-TP53 isogenic cell lines and over several log2 fold ranges of E:T ratios (Fig. 1D,F,G). CAR T-cells targeting ...

Linking cellular toxicity to low-tier animal toxicity and beyond is crucial within the adverse outcome pathway concept and the 3R framework. This study aimed to determine and compare the bioavailable ...

WATERTOWN, Mass. and GOSSELIES, Belgium, May 13, 2025 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research.

9507Background: First-line treatment with an EGFR tyrosine kinase inhibitor (TKI) is standard of care for patients (pts) ... Concurrent osimertinib plus gefitinib for first-line treatment of ...